Nogo receptor interacts with brain APP and Abeta to reduce pathologic changes in Alzheimer's transgenic mice. - Wikidata - wikimedia - TriplyDB

Nogo receptor interacts with brain APP and Abeta to reduce pathologic changes in Alzheimer's transgenic mice.

Nogo receptor interacts with brain APP and Abeta to reduce pathologic changes in Alzheimer's transgenic mice.

http://www.wikidata.org/entity/Q37065333

about

Quantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease Membrane-type matrix metalloproteinase-3 regulates neuronal responsiveness to myelin through Nogo-66 receptor 1 cleavage Molecular basis of the interactions of the Nogo-66 receptor and its homolog NgR2 with myelin-associated glycoprotein: development of NgROMNI-Fc, a novel antagonist of CNS myelin inhibition Assessment of Nogo-66 receptor 1 function in vivo after spinal cord injury.Sink hypothesis and therapeutic strategies for attenuating Abeta levels.Function of Nogo-A/Nogo-A receptor in Alzheimer's disease.The Neural Stem Cell Microenvironment: Focusing on Axon Guidance Molecules and Myelin-Associated Factors.Nogo receptor 1 regulates Caspr distribution at axo-glial units in the central nervous system.Lingo-1: a novel target in therapy for Alzheimer's disease?One protein, multiple pathologies: multifaceted involvement of amyloid β in neurodegenerative disorders of the brain and retina.The Involvement of the Myelin-Associated Inhibitors and Their Receptors in CNS Plasticity and Injury.The Nogo receptor 2 is a novel substrate of Fbs1.Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS

P2860

Q24293094-8DFC2B7F-B1BF-4A1D-9258-EAE2AEF60CA3 Q28115379-AE5352CB-3036-4FD9-A90B-CA630AB9A507 Q28567486-1200B97D-2160-491A-AD12-85DFAC5AEFEE Q33774255-0245926C-D98E-4E3A-96E3-54ED4F178A09 Q37844327-EB184871-B61B-4436-9F1B-BE246BD30859 Q38366946-5819B81A-4A6A-4E6D-AB20-1D83DD259D26 Q38372245-6FA01311-ED53-430A-A016-D5F88CF16E78 Q38615259-EF21837E-0ABE-4E7E-B0CD-E6CB6549ACD1 Q38717065-3C9549D6-D2A5-4D7A-BDD4-AEE91A516885 Q38873518-3EE6141C-3DAA-4D35-97E9-3473AFC799F2 Q39147473-6A377E03-D7AD-494A-AF50-32B5FD7277EA Q40773206-AF0EBDF5-AC00-4990-9FDB-75741FD5C411 Q57675694-6571BE92-5028-4ADF-9114-2B0DCCB8D41A

P2860

Nogo receptor interacts with brain APP and Abeta to reduce pathologic changes in Alzheimer's transgenic mice.

http://www.wikidata.org/entity/Q37065333

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on December 2007

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nogo receptor interacts with b ...... n Alzheimer's transgenic mice.

@en

Nogo receptor interacts with b ...... n Alzheimer's transgenic mice.

@nl

type

label

Nogo receptor interacts with b ...... n Alzheimer's transgenic mice.

@en

Nogo receptor interacts with b ...... n Alzheimer's transgenic mice.

@nl

prefLabel

Nogo receptor interacts with b ...... n Alzheimer's transgenic mice.

@en

Nogo receptor interacts with b ...... n Alzheimer's transgenic mice.

@nl

P1433

Q37065333-E5699D3F-F8C7-40E2-9DAC-06C172228741

P1476

Q37065333-0704C0F7-FD38-4D75-9AB1-307A8C815103

P2093

Q37065333-FAADD803-2A65-461F-91D2-A289D571489B

P2860

Q37065333-007CED25-C977-430F-A13F-1F78B8B48B6A

Q37065333-05361BC8-72D8-418D-A734-06FBC48119BB

Q37065333-1557D5D0-8E2F-47E4-906B-22D677F769F4

Q37065333-280C5D0F-BFE0-4A8D-BD32-AB9EBEA97353

Q37065333-33E25F9A-9E13-4468-8D0E-0BE519C815E2

Q37065333-3BF797A3-48FD-4362-9FA4-80512DA720FC

Q37065333-532544CA-F97B-4E72-A622-C0773195CF6F

Q37065333-5CD4EA78-B755-40A6-9C3E-27315385F702

Q37065333-67E44171-EA3B-4309-913C-031AA4022DB4

Q37065333-680343CA-5948-44FE-8EB8-941EAB32308A

P304

Q37065333-DAEF06BD-BA0C-44D1-8E4D-FE0BAD772E8E

P31

Q37065333-9646D463-176A-4487-B3F6-6D6B062B3639

P356

Q37065333-762C3534-76D2-4754-AD82-90B4D98B9881

P433

Q37065333-3B5BB416-F852-45CC-8C3D-75D88AC15293

P478

Q37065333-8B464264-F43A-47C1-89FE-FA7017CD06F3

P50

Q37065333-AEB25D1D-7CAF-4B58-B06A-15BD2BE6E219

Q37065333-F8F92B32-9E99-4B07-87B1-649172538659

P577

Q37065333-20D1EA45-4566-4BB2-BE32-BAE36F38DB59

P698

Q37065333-41BE48D2-0F87-4186-AB0D-16AA94D68482

P921

Q37065333-38799225-0CEA-4828-A431-7ED06D3CA62C

P932

Q37065333-49894F41-A74E-4640-9BBD-475E67FF381C

P356

156720507783018235

P1433

Current Alzheimer Research

P1476

Nogo receptor interacts with b ...... in Alzheimer's transgenic mice

@en

P2093

James H Park

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein

beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology

Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors

Nogo-66 receptor antagonist peptide promotes axonal regeneration

Neogenin mediates the action of repulsive guidance molecule

Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor

Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease

P304

568-570

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/156720507783018235

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Stephen M. Strittmatter

P577

2007-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

18220524

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

2846284

http://www.w3.org/2001/XMLSchema#string